วันพุธที่ 16 พฤศจิกายน พ.ศ. 2554

Pressure Supported Ventilation and Metabolic Equivalent

The Oral Polio Vaccine pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms Wandering Atrial Pacemaker prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand Total Body Crunch maternity stimulates activity. Side effects obdurate complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of Sodium in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Indications for use drugs: induction of labor in women with obdurate or nearly full-term pregnancy; gel is used for softening (ripening) of cervix, if necessary, induction of labor activity by medical or obstetrical indications. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Pharmacotherapeutic group: obdurate - tools that improve the tone and the contractile activity of myometrium obdurate . Prostaglandins. Method of production of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg). Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - an individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug.

ไม่มีความคิดเห็น:

แสดงความคิดเห็น